FDA encourages the early adoption of advanced manufacturing technologies (AMTs) that have the potential to benefit patients by improving manufacturing and supply dependability and optimizing development time of drug and biological products.
Similar Posts
Gerber Products Company Announces Voluntary Recall of Limited Batches of Arrowroot Biscuits Out of an Abundance of Caution Due to Potential Presence of Foreign Material Following Supplier Recall
January 26, 2026 — Gerber Products Company is initiating a voluntary recall of limited batches of Gerber® Arrowroot Biscuits out of an abundance of caution due to the potential presence of soft plastic and/or paper pieces that should not be consumed. The material comes from an arrowroot flour suppliA.S.K. Foods, LLC Issues Allergy Alert on Undeclared Soy in Publix Rice & Pigeon Peas
A.S.K. Foods, LLC of Palmyra, PA is recalling select 32 oz. containers of Publix Rice & Pigeon Peas because it contains undeclared soy. People who have an allergy or severe sensitivity to soy run the risk of serious or life-threatening allergic reaction if they consume this product.FDA-Recognized Antimicrobial Susceptibility Test Interpretive Criteria
FDA-Recognized Antimicrobial Susceptibility Test Interpretive CriteriaHunter Holmes McGuire Veterans Admin Medical Center, Richmond, VA 483 Issued 3/11/2015
Hunter Holmes McGuire Veterans Admin Medical Center, Richmond, VA 483 Issued 3/11/2015FDA Launches Crackdown on Deceptive Drug Advertising
The U.S. Department of Health and Human Services and the Food and Drug Administration today announced sweeping reforms to rein in misleading direct-to-consumer pharmaceutical advertisements.Owen Biosciences, Inc. – 710275 – 10/30/2025
CGMP/Finished Pharmaceuticals/Adulterated